SOUTH AFRICA – Aspen Pharmacare, Africa’s leading pharmaceutical company, has announced plans to produce generic versions of GLP-1 receptor agonists—medications used to treat type 2 diabetes and obesity—by 2026. This strategic move aims to provide more affordable treatment options in emerging markets where the burden of these conditions is significant and access to medication is […]
USA – China has pulled ahead of the United States in critical areas of biotechnology, prompting urgent calls for federal action from the National Security Commission on Emerging Biotechnology. In a comprehensive report submitted to Congress and the White House, the bipartisan commission—composed of lawmakers, scientists, and former defense officials. It warns that China’s strategic […]
USA – Bain Capital is on the verge of acquiring HealthEdge, a leading U.S.-based healthcare software provider, in a deal valued at US $2.6 billion including debt, according to sources familiar with the matter. The transaction, expected to be announced shortly, underscores Bain’s strategic push into healthcare technology and highlights the ongoing appeal of software […]
INDIA – Max Healthcare Institute is set to significantly scale its footprint across India, unveiling plans to invest ₹6,000 crore (US $708 million) by 2028 to add 3,700 hospital beds. This strategic expansion will elevate its capacity from nearly 5,000 beds across 22 facilities to an estimated 30 hospitals nationwide. Announced during the inauguration of […]
USA – Eli Lilly’s stock took a hit after CVS Health, one of the largest U.S. pharmacy benefit managers (PBMs), announced it would no longer cover the company’s obesity treatment Zepbound (tirzepatide). The decision sent Lilly’s shares tumbling nearly 12%, despite the company posting a 45% jump in first-quarter revenues, largely driven by strong performance […]
USA – The National Institutes of Health (NIH) has announced it will eliminate all foreign subawards by October—a decision expected to sever billions of dollars in funding to research institutions and hospitals outside the United States. This sweeping policy shift, revealed in a new NIH directive, signals a significant retreat from international research cooperation by […]
USA – After a period of moderation, healthcare mergers and acquisitions (M&A) are set for a strong rebound in 2025, according to PwC’s latest outlook. The advisory firm projects that deal volume will remain resilient—hovering between 1,300 to 1,400 transactions annually—buoyed by extended private equity hold periods, a maturing pipeline of sell-ready assets, and the […]
AUSTRALIA – Bain Capital is reportedly positioning itself to acquire a significant portion of Healthscope’s US $1.4 billion debt, a strategic move that could grant the private equity firm substantial influence—or even control—over Australia’s second-largest private hospital operator. Healthscope, owned by Brookfield Asset Management since a US $4.4 billion acquisition in 2019, operates 38 hospitals […]
UAE – PureHealth Holding PJSC, the Middle East’s largest healthcare provider, has announced an agreement to acquire a 60% stake in Hellenic Healthcare Group (HHG) from CVC Capital Partners in a deal valued at €2.2 billion (US $2.3 billion). The acquisition aligns with PureHealth’s global expansion strategy, aiming to diversify its revenue base and enhance […]
USA – Bain Capital has submitted a formal offer to acquire Surgery Partners, Inc. for US $3.2 billion, with the intent to transition the publicly traded surgical facilities operator into a privately held company. Currently under review by Surgery Partners’ board, the proposal would mark a strategic deepening of Bain Capital’s position in the ambulatory […]
UK – GlaxoSmithKline (GSK) is stepping into a pivotal moment in the treatment of chronic obstructive pulmonary disease (COPD) with its anti-IL-5 biologic Nucala (mepolizumab). The company aims to rival Sanofi and Regeneron’s Dupixent (dupilumab), which currently leads the biologics market for COPD. Newly published data from the MATINEE trial, featured in the New England […]
USA – Senator Susan Collins, the Republican chair of the Senate Appropriations Committee, has delivered a forceful rebuke of the Trump administration’s sweeping cuts to biomedical research. She warned that the actions could severely damage America’s global leadership in scientific innovation. Speaking at a committee meeting on Thursday morning, Collins emphasized that consistent funding is […]
XRP HEALTHCARE L.L.C | License Number: 2312867.01 | Dubai | © Copyright 2025 | All Rights Reserved